Inventor · disambiguated record
Chandra Vargeese
Also filed as: VARGEESE CHANDRA
55 granted patents·82 pending applications·2,600 citations·filing 1990–2025
99Inventor score
Top patents by PatentIndex Score
137 records- 0199US10000754B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2017·Granted Jun 19, 2018·35 cites·21 claims
- 0299US9771588B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted Sep 26, 2017·44 cites·52 claims
- 0399US9732344B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2016·Granted Aug 15, 2017·43 cites·29 claims
- 0499US9657294B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted May 23, 2017·36 cites·23 claims
- 0599US9181551B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2014·Granted Nov 10, 2015·102 cites·82 claims
- 0698US7893302B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2009·Granted Feb 22, 2011·152 cites·1 claims
- 0798US7491805B2Conjugates and compositions for cellular deliverySIRNA THERAPEUTICS INC·Filed 2004·Granted Feb 17, 2009·273 cites·4 claims
- 0898US7404969B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2006·Granted Jul 29, 2008·363 cites·10 claims
- 0997US7964578B2Conjugates and compositions for cellular deliverySIRNA THERAPEUTICS INC·Filed 2008·Granted Jun 21, 2011·66 cites·9 claims
- 1097US7833992B2Conjugates and compositions for cellular deliveryMERCK SHARPE & DOHME·Filed 2003·Granted Nov 16, 2010·149 cites·3 claims
- 1197US7691405B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2008·Granted Apr 6, 2010·51 cites·10 claims
- 1297US7514099B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2006·Granted Apr 7, 2009·67 cites·1 claims
- 1397US6995259B1Method for the chemical synthesis of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2001·Granted Feb 7, 2006·103 cites·16 claims
- 1497US6168778B1Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand ComplexesNEXSTAR PHARMACEUTICALS INC·Filed 1997·Granted Jan 2, 2001·244 cites·35 claims
- 1597US6051698AVascular endothelial growth factor (VEGF) nucleic acid ligand complexesFiled 1997·Granted Apr 18, 2000·294 cites·21 claims
- 1696US11634710B2Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2020·Granted Apr 25, 2023·10 cites·9 claims
- 1795US10662428B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2019·Granted May 26, 2020·5 cites·4 claims
- 1895US10450568B2Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2018·Granted Oct 22, 2019·61 cites·13 claims
- 1994US11013757B2Oligonucleotides, compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2017·Granted May 25, 2021·19 cites·20 claims
- 2094US7777023B2Method for the chemical synthesis of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2005·Granted Aug 17, 2010·23 cites·20 claims
- 2194US6989442B2Deprotection and purification of oligonucleotides and their derivativesSIRNA THERAPEUTICS INC·Filed 2002·Granted Jan 24, 2006·43 cites·24 claims
- 2293US11603532B2Oligonucleotide compositions and methods of use thereofWAVE LIFE SCIENCES LTD·Filed 2018·Granted Mar 14, 2023·11 cites·20 claims
- 2393US10724035B2Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2017·Granted Jul 28, 2020·24 cites·12 claims
- 2493US10479995B2Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2016·Granted Nov 19, 2019·30 cites·9 claims
- 2593US10351852B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2017·Granted Jul 16, 2019·5 cites·47 claims
- 2693US7641915B2Lipid nanoparticle based compositions and methods for the delivery of biologically active moleculesSIRNA THERAPEUTICS INC·Filed 2008·Granted Jan 5, 2010·19 cites·1 claims
- 2792US11739325B2Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2018·Granted Aug 29, 2023·12 cites·23 claims
- 2892US9504747B2Lipids and lipid compositions for the delivery of active agentsBARYZA JEREMY LEE·Filed 2014·Granted Nov 29, 2016·10 cites·21 claims
- 2992US7935812B2RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)MERCK SHARP & DOHME·Filed 2009·Granted May 3, 2011·28 cites·13 claims
- 3092US7517864B2RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2005·Granted Apr 14, 2009·16 cites·16 claims
- 3192US7205399B1Methods and reagents for oligonucleotide synthesisSIRNA THERAPEUTICS INC·Filed 2002·Granted Apr 17, 2007·67 cites·20 claims
- 3291US12428442B2Compounds, compositions and methods for synthesisWAVE LIFE SCIENCES LTD·Filed 2023·Granted Sep 30, 2025·1 cites·21 claims
- 3391US11718638B2Compounds, compositions and methods for synthesisWAVE LIFE SCIENCES LTD·Filed 2018·Granted Aug 8, 2023·10 cites·20 claims
- 3491US11597927B2Oligonucleotide compositions and methods of use thereofWAVE LIFE SCIENCES LTD·Filed 2018·Granted Mar 7, 2023·11 cites·15 claims
- 3591US11596646B2Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2018·Granted Mar 7, 2023·11 cites·14 claims
- 3689US11608355B2Technologies for oligonucleotide preparationWAVE LIFE SCIENCES LTD·Filed 2018·Granted Mar 21, 2023·10 cites·25 claims
- 3789US9301923B2Lipids, lipid compositions, and methods of using themBARYZA JEREMY·Filed 2014·Granted Apr 5, 2016·28 cites·8 claims
- 3889US6426335B1Vascular endothelial growth factor (VEGF) nucleic acid ligand complexesGILEAD SCIENCES INC·Filed 1997·Granted Jul 30, 2002·73 cites·23 claims
- 3986US10342761B2Method of encapsulating a nucleic acid in a lipid nanoparticle hostNOVARTIS AG·Filed 2015·Granted Jul 9, 2019·5 cites·17 claims
- 4085US10124065B2Lipids and lipid compositions for the delivery of active agentsNOVARTIS AG·Filed 2014·Granted Nov 13, 2018·8 cites·21 claims
- 4184US12486505B2Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2023·Granted Dec 2, 2025·0 cites·15 claims
- 4284US6962784B2Vascular endothelial growth factor (VEGF) nucleic acid ligand complexesGILEAD SCIENCES INC·Filed 2002·Granted Nov 8, 2005·13 cites·17 claims
- 4381US7655790B2Deprotection and purification of oligonucleotides and their derivativesSIRNA THERAPEUTICS INC·Filed 2005·Granted Feb 2, 2010·5 cites·24 claims
- 4478US12391942B2Oligonucleotide compositions and methods of use thereofWAVE LIFE SCIENCES LTD·Filed 2019·Granted Aug 19, 2025·2 cites·32 claims
- 4578US2024117347A1Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
- 4677US7893249B2Deprotection and purification of oligonucleotides and their derivativesSIRNA THERAPEUTICS INC·Filed 2009·Granted Feb 22, 2011·2 cites·19 claims
- 4776US10889815B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2018·Granted Jan 12, 2021·0 cites·27 claims
- 4875US2025066775A1Oligonucleotide compositions and methods thereofWAVE LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 4975US2019194658A1RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)SIRNA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 5074US12435105B2Technologies for oligonucleotide preparationWAVE LIFE SCIENCES LTD·Filed 2023·Granted Oct 7, 2025·0 cites·29 claims
Showing the top 50 of 137 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Chandra Vargeese files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →